SciELO - Scientific Electronic Library Online

 
vol.16 número2Report of a case of cystinuria: Use of diagnostic tools at national levelAdvantages and limitations of cytogenetics in current medicine índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Memorias del Instituto de Investigaciones en Ciencias de la Salud

versão On-line ISSN 1812-9528

Resumo

CLAVIJO COHEN, Germán. The Risks for Women Associated with the Dispensation of Cyclofem in Pharmacies of Bogotá D.C. A Scope Review. Mem. Inst. Investig. Cienc. Salud [online]. 2018, vol.16, n.2, pp.100-106. ISSN 1812-9528.  https://doi.org/10.18004/mem.iics/1812-9528/2018.016(02)100-106.

The legal regulations in Colombia require that the dispensing and administration of Cyclofem in drugstores be supported by a medical prescription. Cyclofem is an injectable intramuscular combination contraceptive (CCI) that contains medroxyprogesterone acetate and estradiol cypionate with an effectiveness of 99.7%. This medication causes heavy, prolonged and irregular bleeding, queasiness, dizziness, weight gain, headache, osteoporosis and increases glucose tolerance and insulin resistance. Only 0.4% of the pharmacies in Bogotá D.C. demanded the presentation of the medical prescription for dispensing and intramuscular administration (I.M) of Cyclofem in accordance with the current legal regulations.

Palavras-chave : drugstores; Cyclofem; medical prescription; dispensation; intramuscular administration.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )